Capecitabine and Cyclophosphamide (XC) as Maintenance Therapy for Advanced Breast Cancer

Clinical trial NCT05876065 · RECRUITING

Trial details

NCT number: NCT05876065
Sponsor: Wenjin Yin
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2023-06-01
Primary completion: 2026-06-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.